Employment |
No Relationships to Disclose |
|
|
Leadership |
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests |
Company: Actym Therapeutics |
Recipient: You |
Company: Pyxis |
Recipient: You |
Company: Tempest Therapeutics |
Recipient: You |
Company: Kanaph Therapeutics |
Recipient: You |
Company: Onc.AI |
Recipient: You |
Company: NeoTX |
Recipient: You |
|
Honoraria |
No Relationships to Disclose |
|
|
Consulting or Advisory Role |
Company: Bristol-Myers Squibb |
Recipient: You |
Company: Merck |
Recipient: You |
Company: Novartis |
Recipient: You |
Company: Tempest Therapeutics |
Recipient: You |
Company: Alphamab Oncology |
Recipient: You |
Company: Abbvie |
Recipient: You |
Company: Bayer |
Recipient: You |
Company: Incyte |
Recipient: You |
Company: Werewolf |
Recipient: You |
Company: Regeneron |
Recipient: You |
Company: Xilio |
Recipient: You |
Company: Pfizer |
Recipient: You |
Company: Bright Peak |
Recipient: You |
Company: Onc.AI |
Recipient: You |
Company: Hotspot Therapeutics |
Recipient: You |
|
Speakers' Bureau |
No Relationships to Disclose |
|
|
Research Funding |
Company: Merck |
Recipient: Your Institution |
Company: Bristol-Myers Squibb |
Recipient: Your Institution |
Company: Abbvie |
Recipient: Your Institution |
Company: Macrogenics |
Recipient: Your Institution |
Company: Astellas Pharma |
Recipient: Your Institution |
Company: Immatics |
Recipient: Your Institution |
Company: Moderna Therapeutics |
Recipient: Your Institution |
Company: Ikena Oncology |
Recipient: Your Institution |
Company: Numab |
Recipient: Your Institution |
Company: Takeda |
Recipient: Your Institution |
Company: Tizona Therapeutics, Inc. |
Recipient: Your Institution |
|
Patents, Royalties, Other Intellectual Property |
Please describe: Serial #15/612,657 (Cancer Immunotherapy), |
Recipient: You |
Please describe: Serial #PCT/US18/36052 (Microbiome Biomarkers for Anti-PD-1/PD-L1 Responsiveness: Diagnostic, Prognostic and Therapeutic Uses Thereof)
|
Recipient: You |
|
Expert Testimony |
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses |
Company: Merck |
Recipient: You |
|
Other Relationship |
No Relationships to Disclose |
|
|
(OPTIONAL) Uncompensated Relationships |
not answered |
|
|
(OPTIONAL) Open Payments Link |
not answered |
|
|